These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 35418037

  • 1. Phenotypic and genotypic changes of Staphylococcus aureus in the presence of the inappropriate concentration of chlorhexidine gluconate.
    Baseri N, Najar-Peerayeh S, Bakhshi B, Campanile F.
    BMC Microbiol; 2022 Apr 13; 22(1):100. PubMed ID: 35418037
    [Abstract] [Full Text] [Related]

  • 2. The effect of subinhibitory concentration of chlorhexidine on the evolution of vancomycin-intermediate Staphylococcus aureus and the induction of mutations in walKR and vraTSR systems.
    Baseri N, Najar-Peerayeh S, Bakhshi B.
    Infect Genet Evol; 2021 Jan 13; 87():104628. PubMed ID: 33171303
    [Abstract] [Full Text] [Related]

  • 3. The role of the Staphylococcal VraTSR regulatory system on vancomycin resistance and vanA operon expression in vancomycin-resistant Staphylococcus aureus.
    Qureshi NK, Yin S, Boyle-Vavra S.
    PLoS One; 2014 Jan 13; 9(1):e85873. PubMed ID: 24454941
    [Abstract] [Full Text] [Related]

  • 4. [Investigation of antibiotic resistance patterns and reduced vancomycin susceptibilities of methicillin-resistant Staphylococcus aureus isolates: a multi-center study].
    Çıkman A, Aydın M, Gülhan B, Parlak M, Gültepe B, Kalaycı Y, Bayındır Bilmen F, Solmaz S, Özekinci T.
    Mikrobiyol Bul; 2015 Apr 13; 49(2):240-8. PubMed ID: 26167824
    [Abstract] [Full Text] [Related]

  • 5. Insights into the molecular basis of reduced vancomycin susceptibility among three prominent Staphylococcus aureus clonal complexes.
    Malachowa N, Sturdevant DE, Porter AR, Martin G, Martens C, Nair V, Hansen B, Ricklefs S, Jenkins SG, Chen L, Kreiswirth BN, DeLeo FR.
    Microbiol Spectr; 2024 Aug 06; 12(8):e0048624. PubMed ID: 38916317
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of the Presence and Characterization of Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Level Resistance Among Bloodstream Isolates of Methicillin-Resistant Staphylococcus aureus.
    Ozmen Capin BB, Tekeli A, Karahan ZC.
    Microb Drug Resist; 2020 Mar 06; 26(3):238-244. PubMed ID: 31545160
    [Abstract] [Full Text] [Related]

  • 7. VraR Binding to the Promoter Region of agr Inhibits Its Function in Vancomycin-Intermediate Staphylococcus aureus (VISA) and Heterogeneous VISA.
    Dai Y, Chang W, Zhao C, Peng J, Xu L, Lu H, Zhou S, Ma X.
    Antimicrob Agents Chemother; 2017 May 06; 61(5):. PubMed ID: 28289032
    [Abstract] [Full Text] [Related]

  • 8. Clonal spread of Staphylococcus aureus heterogeneously resistant to vancomycin in a university hospital in Korea.
    Kim MN, Hwang SH, Pyo YJ, Mun HM, Pai CH.
    J Clin Microbiol; 2002 Apr 06; 40(4):1376-80. PubMed ID: 11923359
    [Abstract] [Full Text] [Related]

  • 9. Emergence of vancomycin resistant Staphylococcus aureus (VRSA) from a tertiary care hospital from northern part of India.
    Tiwari HK, Sen MR.
    BMC Infect Dis; 2006 Oct 26; 6():156. PubMed ID: 17067393
    [Abstract] [Full Text] [Related]

  • 10. Modulating activity of vancomycin and daptomycin on the expression of autolysis cell-wall turnover and membrane charge genes in hVISA and VISA strains.
    Cafiso V, Bertuccio T, Spina D, Purrello S, Campanile F, Di Pietro C, Purrello M, Stefani S.
    PLoS One; 2012 Oct 26; 7(1):e29573. PubMed ID: 22253738
    [Abstract] [Full Text] [Related]

  • 11. Screening for Intermediately Vancomycin-Susceptible and Vancomycin-Heteroresistant Staphylococcus aureus by Use of Vancomycin-Supplemented Brain Heart Infusion Agar Biplates: Defining Growth Interpretation Criteria Based on Gold Standard Confirmation.
    Khatib R, Riederer K, Sharma M, Shemes S, Iyer SP, Szpunar S.
    J Clin Microbiol; 2015 Nov 26; 53(11):3543-6. PubMed ID: 26311860
    [Abstract] [Full Text] [Related]

  • 12. Evolution of multidrug resistance during Staphylococcus aureus infection involves mutation of the essential two component regulator WalKR.
    Howden BP, McEvoy CR, Allen DL, Chua K, Gao W, Harrison PF, Bell J, Coombs G, Bennett-Wood V, Porter JL, Robins-Browne R, Davies JK, Seemann T, Stinear TP.
    PLoS Pathog; 2011 Nov 26; 7(11):e1002359. PubMed ID: 22102812
    [Abstract] [Full Text] [Related]

  • 13. Clinical and Microbiological Characteristics of Heteroresistant and Vancomycin-Intermediate Staphylococcus aureus from Bloodstream Infections in a Brazilian Teaching Hospital.
    da Costa TM, Morgado PG, Cavalcante FS, Damasco AP, Nouér SA, Dos Santos KR.
    PLoS One; 2016 Nov 26; 11(8):e0160506. PubMed ID: 27575698
    [Abstract] [Full Text] [Related]

  • 14. In vivo development of daptomycin resistance in vancomycin-susceptible methicillin-resistant Staphylococcus aureus severe infections previously treated with glycopeptides.
    Capone A, Cafiso V, Campanile F, Parisi G, Mariani B, Petrosillo N, Stefani S.
    Eur J Clin Microbiol Infect Dis; 2016 Apr 26; 35(4):625-31. PubMed ID: 26815434
    [Abstract] [Full Text] [Related]

  • 15. Downregulation of RNAIII in vancomycin-intermediate Staphylococcus aureus strains regardless of the presence of agr mutation.
    Park C, Shin NY, Byun JH, Shin HH, Kwon EY, Choi SM, Kim SH, Kwon JC, Park SH, Choi JH, Yoo JH, Yoo JI, Chung GT, Lee DG.
    J Med Microbiol; 2012 Mar 26; 61(Pt 3):345-352. PubMed ID: 22016559
    [Abstract] [Full Text] [Related]

  • 16. Development of an Amplicon Nanopore Sequencing Strategy for Detection of Mutations Conferring Intermediate Resistance to Vancomycin in Staphylococcus aureus Strains.
    Moller AG, Petit RA, Davis MH, Read TD.
    Microbiol Spectr; 2023 Feb 14; 11(1):e0272822. PubMed ID: 36688645
    [Abstract] [Full Text] [Related]

  • 17. Characterization of heterogeneous vancomycin-intermediate resistance, MIC and accessory gene regulator (agr) dysfunction among clinical bloodstream isolates of staphyloccocus aureus.
    Harigaya Y, Ngo D, Lesse AJ, Huang V, Tsuji BT.
    BMC Infect Dis; 2011 Oct 25; 11():287. PubMed ID: 22026752
    [Abstract] [Full Text] [Related]

  • 18. Isolates with low-level vancomycin resistance associated with persistent methicillin-resistant Staphylococcus aureus bacteremia.
    Howden BP, Johnson PD, Ward PB, Stinear TP, Davies JK.
    Antimicrob Agents Chemother; 2006 Sep 25; 50(9):3039-47. PubMed ID: 16940100
    [Abstract] [Full Text] [Related]

  • 19. Prevalence of vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous VISA among methicillin-resistant S. aureus with high vancomycin minimal inhibitory concentrations in Taiwan: A multicenter surveillance study, 2012-2013.
    Huang SH, Chen YC, Chuang YC, Chiu SK, Fung CP, Lu PL, Wang LS, Wu TL, Wang JT.
    J Microbiol Immunol Infect; 2016 Oct 25; 49(5):701-707. PubMed ID: 26320398
    [Abstract] [Full Text] [Related]

  • 20. Investigating the effect of an identified mutation within a critical site of PAS domain of WalK protein in a vancomycin-intermediate resistant Staphylococcus aureus by computational approaches.
    Baseri N, Najar-Peerayeh S, Bakhshi B.
    BMC Microbiol; 2021 Sep 02; 21(1):240. PubMed ID: 34474665
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.